HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation.

Abstract
Ischemia-reperfusion (I/R) has been shown to cause microvascular dysfunction and to alter the appearance of the glycocalyx in electron micrographs. We hypothesized that I/R injury might alter the structure and/or permeability of the glycocalyx. Prior work had shown a role for adenosine in protection from I/R injury, and, therefore, we also explored the idea that activation of the adenosine A(2A) receptor would attenuate I/R glycocalyx injury. Here, we report that I/R causes a rapid and dramatic decrease in the ability of the glycocalyx to exclude FITC-Dextran 70 (Dex70). Over a reperfusion period of 45 min, the glycocalyx dye exclusion zone for Dex70 decreased by one-half in capillaries and postcapillary venules, whereas the red blood cell exclusion zone was very slightly reduced in capillaries only. Pretreatment with the A(2A) agonist ATL-146e significantly inhibited the changes in both vessel types. The modifications of the glycocalyx appear to be an early step in the inflammatory cascade typically associated with reperfusion injury, and adenosine A(2A) receptor activation may play a role in protection from this injury.
AuthorsSteven H Platts, Joel Linden, Brian R Duling
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 284 Issue 6 Pg. H2360-7 (Jun 2003) ISSN: 0363-6135 [Print] United States
PMID12560210 (Publication Type: Journal Article)
Chemical References
  • ATL 146e
  • Cyclohexanecarboxylic Acids
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Purines
  • Receptor, Adenosine A2A
  • Triazines
  • Triazoles
  • ZM 241385
Topics
  • Animals
  • Arterioles (pathology)
  • Biotransformation (physiology)
  • Capillaries (pathology)
  • Cyclohexanecarboxylic Acids (pharmacology)
  • Erythrocytes (physiology)
  • Glycocalyx (pathology)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Skeletal (pathology)
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Purines (pharmacology)
  • Receptor, Adenosine A2A
  • Reperfusion Injury (pathology)
  • Triazines (pharmacology)
  • Triazoles (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: